These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29777297)

  • 21. Bioresorbable vascular scaffolds in coronary chronic total occlusions revascularization: safety assessment related to struts coverage and apposition in 6-month OCT follow-up.
    Abellas-Sequeiros RA; Ocaranza-Sanchez R; Trillo-Nouche R; Gonzalez-Juanatey C; Gonzalez-Juanatey JR
    Heart Vessels; 2017 Sep; 32(9):1077-1084. PubMed ID: 28432385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Polymeric Bioresorbable Vascular Scaffold Versus an Everolimus-Eluting Stent in ST-Segment Elevation Myocardial Infarction.
    Wernly B; Latib A; Ielasi A; Jung C
    J Invasive Cardiol; 2019 Sep; 31(9):E271-E272. PubMed ID: 31478894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-Up.
    Serruys PW; Ormiston J; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Chevalier B; Smits P; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Wasungu L; Ediebah D; Veldhof S; Onuma Y
    J Am Coll Cardiol; 2016 Feb; 67(7):766-76. PubMed ID: 26892411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).
    Brugaletta S; Gori T; Low AF; Tousek P; Pinar E; Gomez-Lara J; Scalone G; Schulz E; Chan MY; Kocka V; Hurtado J; Gomez-Hospital JA; Münzel T; Lee CH; Cequier A; Valdés M; Widimsky P; Serruys PW; Sabaté M
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):189-197. PubMed ID: 25616924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and design of the COBRA II trial.
    Bennett J; Adriaenssens T; Desmet W; Dubois C
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):843-853. PubMed ID: 27184586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary Artery Aneurysm After Bioresorbable Scaffold Implantation in a Woman With an Acute Coronary Syndrome.
    Cereda AF; Canova PA; Oreglia JA; Soriano FS
    J Invasive Cardiol; 2017 Jul; 29(7):E77-E78. PubMed ID: 28667808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry.
    La Manna A; Miccichè E; D'Agosta G; Tensol Rodrigues Pereira G; Attizzani GF; Capranzano P; Capodanno D; Tamburino C
    Int J Cardiol; 2018 Feb; 253():45-49. PubMed ID: 29137819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronary Artery Healing Process after Bioresorbable Scaffold in Patients with Non-ST-Segment Elevation Myocardial Infarction: Rationale, Design, and Methodology of the HONEST Study.
    Fallesen CO; Maehara A; Antonsen L; Nørregaard Hansen K; Noori M; Flensted Lassen J; Junker A; Hansen HS; Okkels Jensen L
    Cardiology; 2021; 146(2):161-171. PubMed ID: 33524985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary Plaque Characteristics Associated With Reduced TIMI (Thrombolysis in Myocardial Infarction) Flow Grade in Patients With ST-Segment-Elevation Myocardial Infarction: A Combined Optical Coherence Tomography and Intravascular Ultrasound Study.
    Higuma T; Soeda T; Yamada M; Yokota T; Yokoyama H; Nishizaki F; Xing L; Yamamoto E; Bryniarski K; Dai J; Lee H; Okumura K; Jang IK
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27609831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update.
    Toušek P; Kočka V; Malý M; Kozel M; Petr R; Hajsl M; Jarkovský J; Lisa L; Buděšínský T; Widimský P
    EuroIntervention; 2016 May; 12(1):23-9. PubMed ID: 27173858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optical coherence tomography guidance for percutaneous coronary intervention with bioresorbable scaffolds.
    Caiazzo G; Longo G; Giavarini A; Kilic ID; Fabris E; Serdoz R; Mattesini A; Foin N; Secco GG; De Rosa S; Indolfi C; Di Mario C
    Int J Cardiol; 2016 Oct; 221():352-8. PubMed ID: 27404705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fate of post-procedural malapposition of everolimus-eluting polymeric bioresorbable scaffold and everolimus-eluting cobalt chromium metallic stent in human coronary arteries: sequential assessment with optical coherence tomography in ABSORB Japan trial.
    Sotomi Y; Onuma Y; Dijkstra J; Miyazaki Y; Kozuma K; Tanabe K; Popma JJ; de Winter RJ; Serruys PW; Kimura T
    Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):59-66. PubMed ID: 28158421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioresorbable vascular scaffolds in STEMI patients: multimodality imaging comparison in mid-term perspective.
    Marchese G; Petr R; Tousek P; Widimsky P; Kocka V
    Minerva Cardioangiol; 2016 Aug; 64(4):411-8. PubMed ID: 27070202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
    Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-Scaffold Neovascularization 24 Months After Bioresorbable Vascular Scaffold Implantation in a Patient With ST-Segment Elevation Myocardial Infarction.
    Tomaniak M; Kochman J; Kołtowski Ł; Pietrasik A; Rdzanek A; Filipiak KJ; Opolski G; Regar E
    JACC Cardiovasc Interv; 2017 Jul; 10(13):e123-e125. PubMed ID: 28624381
    [No Abstract]   [Full Text] [Related]  

  • 36. Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial.
    Onuma Y; Sotomi Y; Shiomi H; Ozaki Y; Namiki A; Yasuda S; Ueno T; Ando K; Furuya J; Igarashi K; Kozuma K; Tanabe K; Kusano H; Rapoza R; Popma JJ; Stone GW; Simonton C; Serruys PW; Kimura T
    EuroIntervention; 2016 Oct; 12(9):1090-1101. PubMed ID: 27597270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managing distorted ABSORB Scaffold in left main during anomalous LMCA stenting.
    Rath PC; Reddy KC; Agarwala MK; Purohit BV
    Indian Heart J; 2015; 67(3):268-70. PubMed ID: 26138187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of acute scaffold recoil after implantation of the everolimus-eluting bioresorbable scaffold: an optical coherence tomography assessment in native coronary arteries.
    Sato T; Jose J; El-Mawardy M; Sulimov DS; Tölg R; Richardt G; Abdel-Wahab M
    Int J Cardiovasc Imaging; 2017 Feb; 33(2):145-152. PubMed ID: 27761749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abluminal Neointimal Healing by Optical Coherence Tomography Assessment After Drug-Eluting Stent Implantation on Organized Recanalized Thrombus.
    Camacho Freire SJ; Limpo B; León Jiménez J; Gómez Menchero AE; Roa Garrido J; Cardenal Piris R; Díaz Fernández JF
    J Invasive Cardiol; 2017 Nov; 29(11):E161-E162. PubMed ID: 29086734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-year follow-up after bioresorbable vascular scaffold implantation in STEMI patients - Results from PRAGUE-19 study.
    Toušek P; Kočka V; Malý M; Kozel M; Robert P; Hajšl M; Jarkovský J; Widimský P
    Int J Cardiol; 2016 Apr; 209():20-1. PubMed ID: 26878467
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.